ReValve Solutions Announces Successful First-in-Human with Next Generation TMVR Technology

Contributed by: Business Wire

Logo

Tags

Health

Medical Devices

Surgery

Health Technology

Clinical Trials

Cardiology

Biotechnology

TMVR

More Like This

PR Newswire associated0

Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval

PR Newswire associated0

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

Business Wire embedded0

CroíValve Announces $16 Million Equity Financing to Fund US Early Feasibility Study of Novel Transcatheter Tricuspid Device

Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023

PR Newswire associated0

Meril Champions Innovation with Myval Octapro THV Launch at GISE 2024 & PCR LondonValves 2024

MERIL Announces Successful Primary Outcomes of Next-Gen Myval THV Series in Major RCT, Presented at EuroPCR 2024 - Earns Prestigious Late Breaking Trial Status & The LANCET Acceptance

PR Newswire associated0

NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation

PR Newswire associated0

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study